Enhancing Immune Checkpoint Inhibitor Therapy in Kidney Cancer
Abstract
The purpose of this work is to develop strategies to enhance immune checkpoint inhibition in kidney cancer. The work is designed to test different strategies to induce or enhance the abscopal in a kidney cancer model by combining ablative techniques or TLR agonists with PD1 inhibitors. Funds were transferred to UT Southwestern mid 2017. The PI is in the process of getting IACUC/ACURO approval for the proposed animal studies.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2017
- Accession Number
- AD1049458
Entities
People
- Hans-joerg Hammers
Organizations
- University of Texas Southwestern Medical Center